DrugPatentWatch Database Preview
Anchen Pharms Company Profile
What is the competitive landscape for ANCHEN PHARMS, and what generic and branded alternatives to ANCHEN PHARMS drugs are available?
ANCHEN PHARMS has twenty-six approved drugs.
There are two tentative approvals on ANCHEN PHARMS drugs.
Summary for Anchen Pharms
| US Patents: | 0 |
| Tradenames: | 22 |
| Ingredients: | 22 |
| NDAs: | 26 |
Drugs and US Patents for Anchen Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Anchen Pharms | BUPROPION HYDROCHLORIDE | bupropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 091459-002 | Jun 9, 2011 | AB1 | RX | No | No | See Pricing | See Pricing | ||||
| Anchen Pharms | TRAMADOL HYDROCHLORIDE | tramadol hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 200491-001 | Jun 27, 2012 | AB2 | RX | No | No | See Pricing | See Pricing | ||||
| Anchen Pharms | DULOXETINE HYDROCHLORIDE | duloxetine hydrochloride | CAPSULE, DELAYED REL PELLETS;ORAL | 090780-003 | Oct 28, 2015 | AB | RX | No | No | See Pricing | See Pricing | ||||
| Anchen Pharms | LAMOTRIGINE | lamotrigine | TABLET, EXTENDED RELEASE;ORAL | 201374-001 | Dec 26, 2012 | AB | RX | No | No | See Pricing | See Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
